Prediction: SMCI Stock Will Reach Sixty by 2027, Analysts Say
SMCI's Q3 FY2026 revenue surged and guidance was raised, but investors are weighing whether the stock can reach $60 b...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesSMCI's Q3 FY2026 revenue surged and guidance was raised, but investors are weighing whether the stock can reach $60 b...
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
A new Solana-based utility token kicked off Phase 1 of its presale with a fixed price and a $0.50 listing target, as ...
Vietnam and the Philippines have been upgraded to upper-middle-income status, signaling a new growth phase and bringi...
CoreWeave sits at the intersection of explosive AI demand and a looming debt challenge. A multi-billion backlog canno...
IBM shares have surged on AI optimism, prompting a disciplined look at entry points. This report analyzes a potential...
FuelCell Energy tumbles 10% as investors lock in gains in a sizzling sector, even as firms announce fresh deals and p...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
After a staggering 453% surge, investors face a crossroads: take profits now or double down on a company reshaping th...
Trump's remarks about controlling the Strait of Hormuz sent risk-off waves through crypto markets, with Bitcoin hover...
Airbnb's path through 2026 to 2030 hinges on travel demand, new services, and pricing power. This report lays out sce...
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...